 CAMPBELL, Calif., Dec. 11, 2020 GLOBE NEWSWIRE -- VIVUS, Inc. the Company, a biopharmaceutical company, today announced that it has received approval from the United States Bankruptcy Court for the District of Delaware the Bankruptcy Court on its Second Amended Joint Prepackaged Chapter 11 Plan of Reorganization of VIVUS, Inc. and Its Affiliated Debtors Docket No. 339 the Plan. 